Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A daily pill slowed type 1 diabetes progression in newly diagnosed patients, preserving insulin production.
A daily pill containing baricitinib, a drug used for autoimmune conditions like rheumatoid arthritis, showed promise in slowing type 1 diabetes progression in recently diagnosed patients.
A two-year follow-up of the BANDIT trial found it preserved insulin-producing cells, stabilized blood sugar, and reduced insulin needs, but benefits stopped when the drug was discontinued.
Researchers believe further trials may lead to a treatment that delays or prevents insulin dependence, with potential availability within five years.
9 Articles
Una píldora diaria disminuyó la progresión de la diabetes tipo 1 en pacientes recién diagnosticados, preservando la producción de insulina.